|
Market Closed -
Other stock markets
|
Pre-market 08:31:14 | |||
| 39.07 USD | +1.48% |
|
40.65 | +4.04% |
| 07-29 | Rigel Pharmaceuticals, Inc. Selects Onco360 Oncology Pharmacy As A National Pharmacy Partner For VEPPANU (Vepdegestrant) | CI |
| 07-01 | Rigel Pharmaceuticals, Inc. Announces Board Changes | CI |
| Market Cap | 723M 635M 593M 544M 1.02B 69.24B 1.04B 7.03B 2.75B 34.26B 2.71B 2.66B 118B | P/E 2026 * |
11.1x | P/E 2027 * | 11.1x |
|---|---|---|---|---|---|
| Enterprise Value | 723M 635M 593M 544M 1.02B 69.24B 1.04B 7.03B 2.75B 34.26B 2.71B 2.66B 118B | EV / Sales 2026 * |
2.59x | EV / Sales 2027 * | 2.13x |
| Free-Float |
96.61% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Rigel Pharmaceuticals, Inc.
| 1 day | +1.48% | ||
| 1 week | +3.36% | ||
| Current month | -0.13% | ||
| 1 month | +0.08% | ||
| 3 months | +33.71% | ||
| 6 months | +11.12% | ||
| Current year | -8.78% |
| 1 week | 35.01 |  | 39.95 |
| 1 month | 35.01 | | 43.99 |
| Current year | 24.95 | | 49.1 |
| 1 year | 20.28 | | 52.24 |
| 3 years | 7.12 | | 52.24 |
| 5 years | 6.4 | | 52.24 |
| 10 years | 6.4 | | 55 |
| Manager | Title | Age | Since |
|---|---|---|---|
Raul Rodriguez
CEO | Chief Executive Officer | 65 | 2014-11-20 |
Dean Schorno
DFI | Director of Finance/CFO | 63 | 2018-05-28 |
Raymond Furey
CMP | Compliance Officer | 58 | 2022-11-30 |
| Director | Title | Age | Since |
|---|---|---|---|
Walter Moos
BRD | Director/Board Member | 71 | 1997-02-28 |
Raul Rodriguez
BRD | Director/Board Member | 65 | 2014-11-20 |
Gregg Lapointe
CHM | Chairman | 67 | 2022-04-30 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 7/8/26 | Free | Chief Technology Officer | 24,400 | 0.1319% | ||
| 6/22/26 | Sell | Director | -2,500 | 0.0135% | ||
| 6/17/26 | Free | Compliance Officer | 7,394 | 0.0400% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.48% | +3.36% | +96.33% | +193.76% | 723M | |
| -0.87% | +4.04% | +58.60% | +163.92% | 1,079B | |
| -0.45% | +3.87% | +57.95% | +52.18% | 640B | |
| +0.04% | +3.95% | +37.69% | +74.54% | 465B | |
| -2.12% | +1.46% | +36.59% | +31.04% | 353B | |
| -1.62% | +0.05% | +34.41% | +40.24% | 301B | |
| -2.69% | +1.12% | +11.58% | +14.70% | 271B | |
| -1.82% | +3.76% | +2.26% | -39.14% | 228B | |
| -1.39% | +5.90% | +27.70% | +64.00% | 209B | |
| -1.18% | +1.83% | +16.20% | +72.69% | 165B | |
| Average | -1.11% | +4.68% | +37.93% | +66.79% | 371.04B | |
| Weighted average by Cap. | -1.40% | +4.86% | +41.31% | +77.77% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 279M 245M 229M 210M 393M 26.71B 403M 2.71B 1.06B 13.22B 1.05B 1.02B 45.7B | 339M 298M 278M 255M 478M 32.49B 490M 3.3B 1.29B 16.08B 1.27B 1.25B 55.58B |
| Net income | 69.76M 61.3M 57.22M 52.51M 98.3M 6.68B 101M 679M 265M 3.31B 262M 256M 11.43B | 81M 71.18M 66.44M 60.97M 114M 7.76B 117M 788M 308M 3.84B 304M 298M 13.27B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-29 | US$39.07 | +1.48% | 223,397 |
| 26-07-28 | US$38.50 | +2.97% | 142,576 |
| 26-07-27 | US$37.39 | +1.77% | 229,597 |
| 26-07-24 | US$36.74 | -0.22% | 485,299 |
| 26-07-23 | US$36.82 | -2.59% | 383,198 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- RIGL Stock
Select your edition
All financial news and data tailored to specific country editions
